I N T R O D U C T I O N
The thalamus relays sensory and motor information to the cerebral cortex and receives strong modulatory input back from the cortex. Both thalamocortical and corticothalamic projection neurons send collaterals to ventral thalamic nuclei (Jones 1975) . GABA-containing thalamic reticular nucleus (TRN) neurons provide a major source of inhibitory synaptic input to thalamocortical (TC) neurons (Huguenard and McCormick 2007; Pinault 2004; Schofield et al. 2009 ). By modulating the flow of information through the thalamus, TRN has been hypothesized to play a major role in the control of attention and sensory processing (Guillery et al. 1998; Mayo 2009; McAlonan et al. 2008; Rees 2009; Yu et al. 2009 ). The TRN is also a key player in various types of rhythmic activity associated with certain arousal mechanisms and epileptiform activities (Hughes et al. 2002; Huguenard and McCormick 2007; Huntsman et al. 1999; McCormick and Bal 1997; Sohal et al. 2000; Steriade 1992 Steriade , 1997 Steriade et al. 1993; vonKrosigk et al. 1993) .
Dopamine (DA) is a major neuromodulator in the brain, and its dysfunction has been implicated in multiple human neurological and psychiatric disorders (Di Chiara 2002; Takahashi et al. 2006) . Within thalamic circuitry, DA-dependent actions are thought to play a potentially significant role in emotion, attention, cognition, and complex somatosensory and visual processing (Takahashi et al. 2006) . Alterations in thalamic DA receptors are also implicated in various neurological and psychiatric disorders (Behrendt 2006; Buchsbaum et al. 2006; Di Chiara 2002; Kane et al. 2009; Takahashi et al. 2006; Yasuno et al. 2004) . Anatomical studies have shown that TRN receives a dopaminergic innervation from the substantia nigra pars compacta (SNc) (Anaya-Martinez et al. 2006; Gandia et al. 1993; Garcia-Cabezas et al. 2007 Sanchez-Gonzalez et al. 2005 ) and expresses DA receptors (Khan et al. 1998; Mrzljak et al. 1996) . In addition, TRN receives GABAergic projections from globus pallidus (GP), substantia nigra pars reticulata (SNr), and basal forebrain (Anaya-Martinez et al. 2006; Asanuma and Porter 1990; Asanuma 1994; Bickford et al. 1994; Gandia et al. 1993; Hazrati and Parent 1991; Pare et al. 1990 ). Inhibitory innervations within TRN arise from local collaterals (Deleuze and Huguenard 2006; Lam et al. 2006; Shu and McCormick 2002) . GABAergic terminals within TRN are hypothesized to express D 4 receptors (Ariano et al. 1997; Defagot et al. 1997; Mrzljak et al. 1996) ; however, the action of DA on GABAergic inhibitory signaling in TRN has not been explored. In this study, we found that DA, via presynaptic D 4 receptors, selectively suppresses GABA A -receptor mediated inhibition arising from GP efferents without altering intra-TRN inhibitory signaling.
M E T H O D S
The present study was performed on Sprague Dawley rats (postnatal age 11-20 days). All experimental procedures were carried out in accordance with the National Institute of Health Guidelines for the Care and Use of Laboratory Animals and approved by the University of Illinois Animal Care and Use committee. Animals were maintained with 12 h ON-OFF light/dark schedule in a temperature-controlled environment, and food and water were provided ad libitum.
Brain slices containing thalamus and GP were prepared as previously described with modifications (Lee et al. 2007 ). Rats were deeply anesthetized with sodium pentobarbital (50 mg/kg) and decapitated. The brains were quickly removed and placed into chilled (4°C), oxygenated (5% CO 2 -95% O 2 ) slicing medium containing (in mM) 2.5 KCl, 1.25 NaH 2 PO 4 , 10.0 MgCl 2 , 2.0 CaCl 2 , 26.0 NaHCO 3 , 11.0 glucose, and 234.0 sucrose. Brain slices (250 -300 m thick) were cut in the horizontal plane using a vibrating tissue slicer (Leica, Germany). The slices were transferred to a holding chamber containing oxygenated, physiological solution and incubated (32°C) for Ն1 h prior to recording. The physiological solution contained (in mM) 126.0 NaCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 2.0 MgCl 2 , 2.0 CaCl 2 , 26.0 NaHCO 3 , and 10.0 glucose. The solution was continuously gassed with 95% O 2 -5% CO 2 to a final pH of 7.4. Individual slices were transferred to a submersion type recording chamber maintained at 30 Ϯ 1°C (mean Ϯ SD) and continuously superfused (3 ml/min) with oxygenated solution.
Recording procedures
Whole cell recordings were obtained using a microscope equipped with differential interference contrast (DIC) optics (Axioskop 2FS, Carl Zeiss) similar to that previously used (Govindaiah and Cox 2006a,b) . Specific thalamic nuclei were distinguished using a lowpower objective, and a high-power water-immersion objective was used to identify individual neurons. Recording pipettes were pulled from borosilicate glass tubing and had tip resistances of 4 -7 M⍀. For voltage clamp recordings, the pipette solution contained (in mM) 117.0 Cs-gluconate, 13.0 CsCl, 1.0 MgCl 2 , 0.07 CaCl 2 , 0.1 EGTA, 10.0 HEPES, 2.0 Na 2 -ATP, and 0.4 Na-GTP. For current clamp experiments, the pipette solution contained (in mM) 117.0 K-gluconate, 13.0 KCl, 1.0 MgCl 2 , 0.07 CaCl 2 , 0.1 EGTA, 10.0 HEPES, 2.0 Na 2 -ATP, 0.4 Na-GTP, and 0.3% biocytin. The pH and osmolarity of internal solution were adjusted to 7.3 and ϳ290 mosM, respectively. The internal solution resulted in a 10 mV junction potential that has been corrected in the voltage measures. After forming whole cell configuration, the recording was allowed to stabilize for Ն5 min prior to data acquisition. Inhibitory postsynaptic currents (IPSCs) were optimized by using the cesium (Cs ϩ )-based internal solution and a 0 mV holding potential. All signals were obtained using a Multiclamp 700 amplifier (Molecular Devices, Foster City, CA). For currentclamp recordings, an active bridge circuit was continuously monitored and, if necessary, adjusted to balance the drop in potential produced by passing current through the recording electrode. Recordings included in this study had initial access resistances ranging from 5 to 12 M⍀ and typically remained stable throughout the recording. Data were omitted from the analyses if initial access resistance changed by Ͼ20%. Only neurons that exhibited stable baseline with resting membrane potentials greater than Ϫ55 mV and overshooting action potentials were included for data analyses.
Stimulation procedures
IPSCs were evoked in TRN neurons by electrically stimulating GP (Ͼ0.5 mm lateral to TRN border, Fig. 1A ) using monopolar electrode (200 -700 A, 50 s duration). The stimulus intensity typically ranged from 200 to 400 A, but on occasions, Յ700 A was used if no response was observed at the lower intensities. The actions of the dopaminergic agonists were reversible, thereby suggesting a lack of damage to afferent fibers from the stimulus paradigm. IPSCs were pharmacologically isolated using N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists, Ϯ3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP, 10 M) and 6,7-dinitroquinoxaline-2,3-dione (DNQX; 20 M), respectively. In some neurons, focal application of glutamate via pressure ejection was used to evoke IPSCs in TRN neurons by neighboring neurons.
Drug administration
Concentrated stock solutions were originally prepared in appropriate solvents and diluted in physiological saline to final concentration just prior to use. Agonists were applied via a short bolus into an input line using a syringe pump (Govindaiah and Cox 2005) . DA and SKF38393 were prepared fresh prior to application, and DA was prepared with 0.08% ascorbic acid to prevent oxidation. All antagonists were bath applied Ն5-10 min prior to subsequent agonist application. DA was purchased from Sigma (St. Louis, MO), whereas all remaining compounds were purchased from Tocris (Ellisville, MO).
Data acquisition and analyses
Quantification of evoked IPSC amplitude was performed on 5-10 consecutive responses in each experimental condition using pClamp software (Molecular Devices, Sunnyvale, CA). Miniature IPSCs (mIPSCs) were detected and analyzed using MiniAnalysis software (Synaptosoft, Leonia, NJ). The threshold for mIPSC detection was 10 pA and automatic detection was verified post hoc by visual analysis. The threshold for mIPSC detection was established from the baseline noise level recorded in the presence of GABA A receptor antagonist (SR95531, 10 M) and glutamate receptor antagonists, CPP and DNQX. For quantification of mIPSCs, the average mIPSC frequency was calculated from 60-s time windows: 1 min prior to agonist application and 30 s following agonist application (Govindaiah and Cox 2006b ). To analyze glutamate evoked IPSCs in TRN, the frequency and amplitude of IPSCs were quantified from 1-s windows for five consecutive sweeps for each condition. Due to lack of clear baseline in these cases, the events were manually detected and subsequently the frequency and amplitude of IPSCs quantified using Minianalysis software. Data are expressed as means Ϯ SD unless otherwise noted. Most analyses consisted of Student's t-test, paired test if appropriate, unless otherwise noted. P values Ͻ0.05 were considered statistically significant.
Histology
To confirm that the recordings were obtained from TRN neurons, the morphology of recorded TRN neurons was recovered by filling neurons with a fluorescent dye (Alexa-594, 50 M). Alexa-594 was included in the recording pipette and after recording, a z-stack of images was captured using custom-made two-photon laser scanning microscopy (Prairie Technologies, Middleton, WI) and collapsed using ImageJ software (National Institutes of Health).
R E S U L T S
The results presented in the present study were obtained from 80 TRN neurons. IPSCs in TRN neurons were evoked by GP stimulation (Fig. 1A ) in the presence of NMDA and AMPA receptor glutamatergic antagonists, CPP (10 M) and DNQX (20 M), respectively. The eIPSCs were completely attenuated by the antagonist SR95531 (10 M), indicating that these events are mediated by GABA A receptors (Fig. 1C) .
DA suppresses GABA A receptor-mediated inhibition in TRN neurons
We initially tested the effects of DA on GABA A receptormediated IPSCs evoked by GP stimulation. Short-duration DA application (2.5-25 M, 20 -30 s) reversibly suppressed the eIPSCs amplitudes in a reversible manner (Fig. 2Ai) . Overall DA produced a concentration-dependent suppression of the eIPSC amplitude Յ43 Ϯ 11% with an IC 50 of 5.1 M (Boltzman fit). As illustrated in Fig. 2A2 , DA reduced the eIPSC amplitude by 9 Ϯ 4% (control: 496 Ϯ 143 pA, DA: 455 Ϯ 144 pA, n ϭ 5, P Ͻ 0.001), 37 Ϯ 14% (control: 481 Ϯ 128 pA, DA: 306 Ϯ 108 pA, n ϭ 7, P Ͻ 0.0007), and 43 Ϯ 11% (control: 469 Ϯ 124 pA, DA: 275 Ϯ 100 pA, n ϭ 8, P Ͻ 0.0004) at 2.5, 10, and 25 M, respectively. There was no significant differences between 10 and 25 M DA.
Suppressive actions of DA are mediated via activation of D 4 receptors
We next used selective receptor agonists and antagonists to determine the receptor subtype(s) mediating the DA effect. Similar to DA, the D 2 -like receptor (D 2,3,4 ) agonist quinpirole (5-10 M) and selective D 4 receptor agonist PD168077 (25-50 M) reversibly suppressed eIPSCs in TRN neurons (Fig. 2B) . The suppressive action of quinpirole (10 M) was reproducible to similar degree when applied at the interval of 5-10 min between each application (Fig. 2C) . Short bath application (45 s) of quinpirole significantly reduced the eIPSC amplitude from 544 Ϯ 245 to 347 Ϯ 140 pA (35.1 Ϯ 6.5%, n ϭ 10, P Ͻ 0.0001, Fig. 2B ). The magnitude of the quinpirole effects did not significantly differ from the DA-mediated effects (P Ͼ 0.2). The selective D 4 receptor agonist PD168077 (25-50 M) also suppressed the eIPSC by 37 Ϯ 12% (control: 565 Ϯ 179 pA, PD168077: 355 Ϯ 122 pA, n ϭ 5, P Ͻ 0.0001, Fig. 2B2 ). In contrast, the D 1 -like receptor agonist SKF38393 (10 M) did not alter eIPSC amplitude in all cells tested (3.4 Ϯ 5%, control: 506 Ϯ 182 pA, SKF38393: 501 Ϯ 174 pA, n ϭ 4, P Ͻ 0.2, Fig. 2B ). We further confirmed the suppressive affects of D 2 -like and selective D 4 receptor agonists on eIPSCs using selective antagonists. As illustrated in Fig. 3A , quinpirole produced a significant reduction in the eIPSC amplitude from 366 Ϯ 66 to 233 Ϯ 33 pA (36.3 Ϯ 5%, n ϭ 5, P Ͻ 0.002), which recovered following washout (360 Ϯ 70 pA). In the presence of D 2 -like receptor antagonist sulpiride (10 M), subsequent quinpirole application significantly reduced eIPSC amplitude by 28.3 Ϯ 8.8% (Fig. 3A , n ϭ 5, P Ͻ 0.02). The quinpirole-mediated suppression of the eIPSC amplitude did not significantly differ between control and sulpiride conditions ( Fig. 3A, P ϭ 0.2) . Considering the repeated quinpirole applications in this experiment, in a different population of TRN cells, we made repeated quinpirole applications (10 M, 10 min interval) in control conditions and found that the eIPSC amplitude was suppressed to a similar degree with each quinpirole application, suggesting no desensitization with repeated applications (n ϭ 4, P ϭ 0.27, Fig. 2C ). Of the D 2 -like receptors (D 2 , D 3 , D 4 ), sulpiride has a higher affinity for D 2 and D 3 receptors (Werner et al. 1996) , suggesting the suppression may be mediated via D 4 receptor activation.
To confirm the selective D 4 receptor activation by agonist PD168077, we next tested the actions of PD168077 in the presence of selective D 4 receptor antagonist L745870 (Patel et al. 1997) . PD168077 (25 M) reduced the eIPSC amplitude by 39.0 Ϯ 13.1% in control conditions (Fig. 3B , control: 563 Ϯ 207 pA, PD168077: 341 Ϯ 137 pA, n ϭ 4, P Ͻ 0.001). In the presence of L745870 (50 M), the subsequent application of PD168077 did not alter the eIPSC amplitude ( Following washout, the D 2 -like receptor antagonist sulpiride (10 M) was bath applied, and the subsequent application of quinpirole still significantly attenuates IPSC amplitude. A2: population data illustrating the suppressive actions of quinpirole (**P Ͻ 0.002, n ϭ 5), and this effect is not completely antagonized by sulpiride (*P Ͻ 0.02, n ϭ 5). B1: in a different TRN neuron, PD168077 (25 M) reversibly suppresses the IPSC similar to quinpirole. Following recovery, the selective D 4 receptor antagonist L745870 (50 M) was bath applied, and the subsequent application of PD168077 does not alter IPSC amplitude. B2: population data illustrating reversible suppressive actions of PD168077 (*P Ͻ 0.001, n ϭ 4). In the presence of L745870, PD168077 no longer alters the IPSC (P ϭ 0.1, n ϭ 4). C1: L745870 also blocks the DA-mediated suppression of the IPSC. In different TRN neurons, DA strongly attenuates the IPSC. In the presence of L745870 (50 M), the DA-mediated suppression is greatly reduced. C2: population data illustrating the suppressive actions of DA alone (**P Ͻ 0.007, n ϭ 5) and its reduced action in presence of L745870 (*P Ͻ 0.03, n ϭ 5).
antagonist. In these neurons, DA (10 M) significantly suppressed the eIPSC amplitude (Fig. 3C , control: 522 Ϯ 127 pA, DA: 314 Ϯ 191 pA, n ϭ 5, P Ͻ 0.007). Following recovery, the D 4 receptor antagonist L745870 (25 M) was bath applied for 7-10 min. In the presence of L745870, the subsequent DA application did not alter the eIPSC amplitude significantly (Fig.  3C , control: 519 Ϯ 126 pA, L745870 ϩ DA: 483 Ϯ 120 pA, n ϭ 5, P Ͻ 0.03). Overall, these data indicate that activation of D 4 receptors attenuates evoked inhibitory synaptic transmission arising from GP stimulation.
Presynaptic D 4 receptors modulates GABAergic signaling in TRN
To examine whether the inhibitory actions of DA on IPSCs is mediated by a pre-or postsynaptic action, we studied the effect of DA and quinpirole on eIPSCs produced by paired pulse stimulation as well as their effect on miniature IPSCs (mIPSCs). Paired pulse stimulation within GP (75-125 ms interstimulus intervals, ISI) resulted in paired pulse depression of the eIPSCs in TRN neurons (Fig. 4) . The paired pulse ratio (PPR: IPSC 2 / IPSC 1 ) was calculated prior to and after agonist application. DA (25 M) attenuated the eIPSC and the PPR was significantly increased from 0.67 Ϯ 0.08 to 0.91 Ϯ 0.10 ( Fig. 4A2 ; n ϭ 6, P Ͻ 0.002), indicating a decrease in paired pulse depression. Similar to DA, quinpirole (10 M) also significantly increased the PPR from 0.63 Ϯ 0.04 to 0.79 Ϯ 0.09 ( Fig. 4B ; n ϭ 8, P Ͻ 0.002). The alteration in PPR is consistent with a presynaptic site of action such as a change in release properties (Zucker and Regehr 2002) .
We next tested the effects of DA and dopaminergic agonists on mIPSC activity in TRN neurons. The mIPSCs were pharmacologically isolated using 1 M TTX, 10 M CPP, and 10 M DNQX, and recorded using a holding potential of 0 mV. Under these conditions, quinpirole (10 M, n ϭ 9) and DA (25 M, n ϭ 3) reduced mIPSC frequency but not mIPSC amplitude. Cumulative probability analyses indicate that quinpirole significantly increased the interevent interval (Fig. 5, B and C without significant alterations in mIPSC amplitude (D and E) . Overall quinpirole decreased the frequency of mIPSCs by 37.0 Ϯ 12.5% (control: 1.0 Ϯ 0.4 Hz, quinpirole: 0.6 Ϯ 0.2 Hz, n ϭ 9, P Ͻ 0.001, Fig. 5C ). In contrast, quinpirole did not significantly alter mISPC amplitude (control: 15.6 Ϯ 1.0 pA; quinpirole: 14.7 Ϯ 3.2 pA, n ϭ 9; P ϭ 0.5, Fig. 5E ). The selective alteration in mIPSC frequency, but not mIPSC amplitude, is consistent with a presynaptic site of action.
Previous studies have demonstrated that activation of D 2 -like receptors inhibits Ca 2ϩ currents through a pertussis toxin . A: representative current traces reveal mIPSCs in control and following quinpirole (10 M) application. B: cumulative probability plots for neuron in A illustrating the increase in interevent intervals by quinpirole. C: population data revealing that quinpirole significantly reduces mIPSC frequency (*P Ͻ 0.001, n ϭ 9). D: cumulative probability plot for neuron in A illustrating that mIPSC amplitude is unaltered by quinpirole. E: population data reveal quinpirole does not alter mIPSC amplitude (P ϭ 0.5, n ϭ 9). , leading to an increase in paired pulse ratio (PPR). Scaling of the 1st IPSC clearly illustrates the reduction in paired pulse depression. A2: population data illustrate a significant increase in PPR by DA (*P Ͻ 0.002, n ϭ 6), indicating a reduction in paired pulse depression. B1: in a different neuron, quinpirole (10 M) produces a similar alteration in PPR as DA. B2: population data illustrate a significant increase in PPR by quinpirole (*P Ͻ 0.002, n ϭ 8).
(PTX)-sensitive G protein (G i/o ) (Yan et al. 1997) . To determine whether the presynaptic D 4 receptor-mediated effect involves this G protein subtype, we examined the effect of the sulfhydryl alkylating agent N-ethylmaleimide (NEM), which disrupts coupling of PTX-sensitive G i/o type G proteins to Ca 2ϩ channels (Shapiro et al. 1994) . The suppressive action of D 4 receptor agonist PD168077 on eIPSC was blocked by NEM (Fig. 6) . In control conditions, PD168077 (25 M) reduced the eIPSC amplitude by 36.2 Ϯ 13.7% (n ϭ 5, P Ͻ 0.01). Bath application of NEM (50 M) alone had no effect on the evoked IPSCs. In the presence of NEM, PD168077 produced a smaller suppression of the eIPSC (9.9 Ϯ 4.1%); this is significantly smaller than that in the absence of NEM (P Ͻ 0.02), indicating that NEM-sensitive Gi proteins are coupled to presynaptic D 4 receptors.
As a measure of postsynaptic sensitivity, we tested if the DA and its agonists could alter GABA A receptor-mediated currents in TRN neurons. GABA A receptor-mediated currents were evoked by brief, focal application of the GABA A receptor agonist muscimol at 20-s intervals. Muscimol (50 M, 0.5 s duration) elicited repeatable outward currents (Fig. 7A ) that were completely attenuated by SR95531 (10 M, not shown). The muscimol-induced currents were unaltered by 25 M DA (Fig. 7B , control: 691 Ϯ 167 pA, DA: 667 Ϯ 170, n ϭ 3; P ϭ 0.2,) or 10 M quinpirole (Fig. 7B , control: 766 Ϯ 222, quinpirole: 729 Ϯ 227, n ϭ 6; P Ͻ 0.05). These data suggest that DA does not regulate postsynaptic GABA A receptors in TRN neurons. Overall these data indicate that the dopaminemediated suppression of eIPSCs is due to a presynaptic action, thereby reducing GABA release from their terminals originating from GP.
DA-mediated suppression of inhibition is restricted to GP-TRN pathway
Our results clearly demonstrate that the activation of DA D 4 receptors suppress inhibitory synaptic transmission resulting from electrical stimulation of presumed GP efferents, but it is unclear if this is a general action affecting all inhibitory inputs onto TRN neurons. We next tested if DA could modulate intra-TRN inhibition considering these neurons form chemical synapses with each other (Deleuze and Huguenard 2006; Lam et al. 2006; Shu and McCormick 2002) . To evoke intra-TRN inhibitory responses, we focally applied glutamate via pressure ejection within TRN near our recording. As shown in Fig. 8A , glutamate (500 M, 50 ms) produced an inward current (likely via direct depolarization and/or electrical coupling) along with an increase in spontaneous IPSCs (sIPSCs). These sIPSCs were completely antagonized by a GABA A receptor antagonist SR95531 (Fig. 8A, SR95531 ). The glutamate-evoked IPSCs had an average frequency of 23.7 Ϯ 11.4 Hz (Fig. 8B, n ϭ 6 ). After obtaining a consistent IPSCs resulting from glutamate application, quinpirole (10 M, 45-60 s) was applied via bolus. Quinpirole did not alter the frequency of glutamateevoked sIPSCs (Fig. 8B, control: 23.3 Ϯ 12.7 Hz, PD168077: 20.6 Ϯ 11.5 Hz, n ϭ 5, P ϭ 0.1). Likewise sIPSC amplitudes were also unaltered by either quinpirole (control: 37.7 Ϯ 11.8 pA, quinpirole: 39.7 Ϯ 12.8 pA, n ϭ 5, P ϭ 0.9) or PD168077 (Fig. 8C , control: 35.9 Ϯ 12.3 pA, PD168077: 33.9 Ϯ 11.7 pA, n ϭ 5, P ϭ 0.4). The data suggests that the DA-mediated reduction in inhibitory synaptic transmission in TRN neurons is limited to the GP-TRN inhibition and not intra-TRN inhibition.
D I S C U S S I O N
We demonstrate that the activation of presynaptic D 4 receptors selectively suppresses GABA A receptor-mediated inhibition at pallido-thalamic innervation without altering intra-TRN inhibition (Fig. 7) . The reduction in GP-thalamic inhibition is by reducing GABA release at presynaptic terminals of GP neurons via D 4 receptor activation. Despite the recognized association of D 4 receptors with schizophrenia, attention deficit hyperactivity disorder, and other mental disorders (Oak et al. 2000; Seeman et al. 1993 ), the cellular mechanisms by which D 4 receptors modulate neuronal functions remain elusive. Anatomical studies have shown that D 2 -like dopamine receptors are expressed by GABAergic neurons including TRN and GP (Khan et al. 1998; Mrzljak et al. 1996) ; however, their functional role on inhibitory synaptic transmission has not been explored.
TRN receives GABAergic projections from GP, SNr, and basal forebrain (Anaya-Martinez et al. 2006; Asanuma 1994; Asanuma and Porter 1990; Bickford et al. 1994 ). In addition, TRN neurons form intra-TRN connections via axon collaterals (Huntsman et al. 1999; Shu and McCormick 2002) . Although the precise origin of GABA terminals within the TRN containing the D 4 receptors remains unclear, GP neurons have been shown to express D 4 receptor and its mRNA (Ariano et al. 1997; Defagot et al. 1997; Mrzljak et al. 1996) . Anatomical evidence suggests that TRN neurons receive dopaminergic innervations from substantia nigra pars compacta (AnayaMartinez et al. 2006; Garcia-Cabezas et al. 2007 Sanchez-Gonzalez et al. 2005 ) and expresses DA receptors (Ariano et al. 1997; Defagot et al. 1997; Khan et al. 1998; Mrzljak et al. 1996) . In this study, we have demonstrated a functional role of D 4 receptors exclusively found on GABAergic neurons (Mrzljak et al. 1996) . Our present findings are supported by a evidence suggesting that the activation of D 4 receptors can modulate GABA release in TRN (Floran et al. 2004) .
The dopaminergic system in TRN is thought to play crucial role in sensory gating and has been postulated that some of the manifestations of disorders of dopaminergic transmission may be caused by abnormal TRN function. For example, the TRN plays a central role in the control of attention (Guillery et al. 1998; Mayo 2009; McAlonan et al. 2008; Rees 2009; Yu et al. 2009) , and attention deficit hyperactive disorder (ADHD) is associated with genetic abnormalities of dopamine D 4 receptors (Castellanos and Tannock 2002; LaHoste et al. 1996) . Moreover, TRN lies at the interface of thalamocortical circuits between prefrontal cortex and associated thalamic relay nuclei, thus alterations in TRN signaling will influence the gating properties between these two structures, which could underlie the hypothesized role of TRN in attention mechanisms (Zikopoulos and Barbas 2006). Additionally, abnormal dopaminergic function in the TRN may also contribute to some of the manifestations of Parkinson's disease, such as the sleep disorders (Rye and Jankovic 2002) and the abnormal processing of proprioceptive signals (Dietz 2002) . By its connections with motor-related structures, TRN is thought to play integrative role in motor functions (Anaya-Martinez et al. 2006; Kane et al. 2009; Obeso et al. 2008; Piggott et al. 2007 ). Thus alterations in dopaminergic system in TRN may lead to abnormal motor functions found in Parkinson's disease. In fact, the D 4 receptor-containing GABAergic neurons of the SNr and GP are thought to constitute major links in the basal ganglia loop circuits that regulate the motor thalamus and the cortex in sequence. We propose that activation of SNc neurons lads to release of DA in TRN, and this in turn activates D4 receptor on GP terminals leading to reduced GABA release. The reduced inhibition by activation of SNc neurons may lead to increased excitability of TRN neurons and decrease in output of thalamocortical neurons. Thus activation of D4 receptor can influence the thalamocortical circuit activity.
Thalamic inhibitory mechanisms have been shown to play crucial role in thalamocortical oscillations associated with arousal and sleep mechanisms (Huguenard and McCormick 2007; McCormick and Bal 1997; Sohal et al. 2000 Sohal et al. , 2003 Steriade 1992 Steriade , 1997 vonKrosigk et al. 1993 ). Schizophrenic patients have been reported to show abnormalities in slowwave sleep that are correlated with the state of spindle activity and synchronization of cortical and thalamic activity (Keshavan et al. 1995) . Thus thalamic D 2 -like receptors are thought to play key roles in pathophysiology of schizophrenia (Buchsbaum et al. 2006) . Elevated levels of D 4 receptors have been reported in schizophrenics (Seeman et al. 1993 ). In addition, alterations in thalamic D 2 receptors have been reported in schizophrenia (Takahashi et al. 2006) . Clearly there are a number of different alterations in thalamocortical activities that may result in alterations in sensory processing and attentional modulation, the underlying mechanisms leading to such alterations and further connection to the manifestation of specific schizophrenic behaviors remains speculative (Behrendt 2006) . Nonetheless malfunctioning of DA receptors in TRN is one mechanism that would lead to abnormalities in thalamocortical rhythms and thalamic gating that could contribute to some symptoms of schizophrenia. Additional studies are required to further unravel the functional significance of DA in the thalamus under normal and pathological conditions such as schizophrenia. 
R E F E R E N C E S

